GALMED PHARMACEUTICALS LTD (GLMD) Stock Income Statement
NASDAQ:GLMD - Nasdaq - IL0011313900 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.49M | 17.65M | 32.88M | 30.21M | 22.38M | |||
| Research and Development | 3.57M | 13.00M | 27.22M | 26.08M | 18.18M | |||
| Selling, General, and Administrative Expenses | 3.92M | 4.66M | 5.66M | 4.13M | 4.20M | |||
| Operating Income | -7.49M | -17.65M | -32.88M | -30.21M | -22.38M | |||
| Interest Income/Expense | 591.00K | -190.00K | 460.00K | 1.47M | 1.95M | |||
| Other Income/Expense | -11.00K | -20.00K | -40.00K | -30.00K | -30.00K | |||
| Income Before Taxes | -6.91M | -17.87M | -32.47M | -28.77M | -20.46M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Net Income | -6.91M | -17.87M | -32.47M | -28.77M | -20.46M | |||
| EBITDA | -7.46M | -17.61M | -32.84M | -30.17M | -22.34M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.50 | -10.63 | -19.80 | -20.28 | -14.51 | |||
| Non GAAP EPS | -39.12 | -126.00 | -237.60 | -243.00 | -174.60 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD